Crl Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.01 M
- Revenue Growth 8.57%
- Profit Growth -240.70%
- Ebitda -177.69%
- Net Worth -48.39%
- Total Assets 2.46%
About Crl Diagnostics
Crl Diagnostics Private Limited (CDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 September 2011 and has a history of 13 years and four months. Its registered office is in Delhi, India.
The Corporate was formerly known as Zenex Labs Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.01 M.
Ravi Tomar, Kamal Taya, Manoj Pathak, and Two other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U93000DL2011PTC225518
- Company No.
225518
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Crl Diagnostics Private Limited offer?
Crl Diagnostics Private Limited offers a wide range of products and services, including Medical Test Services, Diagnostic Lab.
Who are the key members and board of directors at Crl Diagnostics?
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ravi Tomar | Director | 26-Sep-2011 | Current |
Kamal Taya | Director | 27-Jan-2016 | Current |
Manoj Pathak | Director | 27-Jan-2016 | Current |
Chandra Tripathi | Director | 27-Jan-2016 | Current |
Nirankar Bali | Director | 27-Jan-2016 | Current |
Financial Performance of Crl Diagnostics.
Crl Diagnostics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.57% increase. The company also saw a substantial fall in profitability, with a 240.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 48.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Crl Diagnostics?
In 2022, Crl Diagnostics had a promoter holding of 65.00% and a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹8.01 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.50 Cr
- Axis Bank Limited : 0.30 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
14 Mar 2022 | Others | ₹2.29 M | Open |
10 Mar 2022 | Others | ₹1.38 M | Open |
23 Feb 2022 | Others | ₹1.38 M | Open |
17 Sep 2020 | Axis Bank Limited | ₹2.97 M | Open |
How Many Employees Work at Crl Diagnostics?
Crl Diagnostics has a workforce of 221 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crl Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crl Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.